Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multi-institutional Randomized Trial Evaluating the Impact of GLP-1 Receptor Agonists in Combination With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

NCT07314528 is registered in ClinicalTrials.gov with St. James's Hospital, Ireland as lead sponsor.

NCT NCT07314528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07314528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multi-institutional Randomized Trial Evaluating the Impact of GLP-1 Receptor Agonists in Combination With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Lead sponsor
St. James's Hospital, Ireland
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
September 30, 2028
Enrollment
42 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glp-1, locally advanced rectal cancer (larc), obesity & overweight, rectal cancer patients, total neoadjuvant therapy